Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 8 de 8
Filtrar
2.
Ren Fail ; 30(6): 603-9, 2008.
Artigo em Inglês | MEDLINE | ID: mdl-18661410

RESUMO

In this study, we evaluated the frequency, clinical presentation, treatment protocols, prognostic factors, and outcome in children with diffuse proliferative lupus nephritis (DPLN). Between June 1990 and December 2004, 46 patients were diagnosed to have systemic lupus erythematosus (SLE), and 26 of them (56.5%) were found to have DPLN. Renal manifestations were present in 25 patients, and the majority of them presented with severe renal findings, such as nephrotic syndrome and renal failure. All patients were given a quadruple therapy protocol including 6-12 monthly courses of methyl prednisolone pulse therapy combined with oral prednisolone, oral cyclophosphamide, azathioprine, and dipyridamole. Nineteen of these patients were regularly followed up with a mean follow-up period of 5.9 years. Complete remission was achieved in 15 of 19 patients, and chronic renal failure developed in four patients. Renal survival rate was calculated to be 78.9% at the end of 5, 10, and 14 years. Although nephrotic range proteinuria, hypoalbuminemia, renal failure, and activity index above 12/24 at presentation seemed to be associated with poor prognosis, no significant difference could be found. Hypertension and chronicity index greater than 6/12 were found to be bad prognostic predictors. We concluded that satisfactory results were achieved with our quadruple therapy protocol; thus, more aggressive and expensive therapies can be avoided and preserved for more serious and persistent diseases.


Assuntos
Protocolos de Quimioterapia Combinada Antineoplásica/administração & dosagem , Nefrite Lúpica/tratamento farmacológico , Nefrite Lúpica/patologia , Adolescente , Azatioprina/administração & dosagem , Biópsia por Agulha , Distribuição de Qui-Quadrado , Criança , Pré-Escolar , Estudos de Coortes , Ciclofosfamida/administração & dosagem , Dipiridamol/administração & dosagem , Relação Dose-Resposta a Droga , Esquema de Medicação , Quimioterapia Combinada , Feminino , Seguimentos , Humanos , Imuno-Histoquímica , Estimativa de Kaplan-Meier , Testes de Função Renal , Nefrite Lúpica/mortalidade , Masculino , Metilprednisolona/administração & dosagem , Probabilidade , Recidiva , Estudos Retrospectivos , Medição de Risco , Índice de Gravidade de Doença , Taxa de Sobrevida , Fatores de Tempo , Resultado do Tratamento
4.
Clin Pediatr (Phila) ; 44(9): 771-6, 2005.
Artigo em Inglês | MEDLINE | ID: mdl-16327963

RESUMO

In this study, the authors aimed to evaluate buccal midazolam as a practical and safe alternative medication for children who suffer from seizures in the emergency setting and in home practice or anywhere. The effects and side effects of buccal midazolam and rectal diazepam were compared in the treatment of acute convulsions in 43 children, ranging in age from 2 months to 12 years who were seen at the emergency service of the children hospital. Midazolam was given on the even days of the month and diazepam was given on the odd days. In the midazolam group, the seizures of 18/23 (78%) patients terminated in 10 minutes; however 5/23 (22%) patients did not respond. In the diazepam group 17/20 (85%) patients responded in 10 minutes, but 3/20 (15%) did not respond. Midazolam was found to be as effective as diazepam and the difference was not statistically significant (p<0.05). Response periods of the 2 drugs showed no significant difference (p>0.05). The need for a second drug for seizures that did not stop with the first drug was equal, and the difference was not statistically significant (p>0.05). They did not observe any serious complications. In conclusion, buccal midazolam is safe and as effective as rectal diazepam for the treatment of seizures.


Assuntos
Diazepam/uso terapêutico , Hipnóticos e Sedativos/uso terapêutico , Midazolam/uso terapêutico , Convulsões/tratamento farmacológico , Administração Bucal , Administração Retal , Criança , Pré-Escolar , Diazepam/administração & dosagem , Serviço Hospitalar de Emergência , Feminino , Humanos , Hipnóticos e Sedativos/administração & dosagem , Lactente , Masculino , Midazolam/administração & dosagem , Convulsões/classificação , Convulsões/etiologia
5.
Int Urol Nephrol ; 41(4): 933-9, 2009 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-18696251

RESUMO

In this study we evaluated the indications, complications, and the spectrum of histopathological results of percutaneous renal needle biopsy (PRNB) performed in our clinic. Between June 1990 and December 2006, 679 PRNBs were performed on native kidneys of 614 children (304 boys, 310 girls) with a mean age of 10.4 years. Most frequent indications for PRNB were nephrotic syndrome (47%), hematuria, and/or proteinuria (15.9%), acute renal failure (14.6%) and complex renal manifestations (18.9%). The overall complication rate was 15.2%. The most common complications were perirenal hematoma (12.4%) and macroscopic hematuria (2.6%). The most frequent histopathological group of diseases were glomerulopathies; these were diagnosed in 376 patients (61.2%) and included membranoproliferative glomerulonephritis (11.1%), mesangial proliferation (10.7%), diffuse proliferative glomerulonephritis (7.7%), and focal segmental glomerulosclerosis (7.3%) as the most frequent. The second most frequent group of histopathology was manifestations secondary to systemic diseases; these were shown in 195 patients (31.8%). Amyloidosis (11.4%) and Henoch-Schönlein nephritis (9.9%) made the majority of this group. In conclusion, our study demonstrated that PRNB is a safe procedure with usually transient complications showing the most frequent renal diseases that cause diagnostic and therapeutic difficulties for pediatric nephrologists.


Assuntos
Biópsia por Agulha/métodos , Nefropatias/patologia , Adolescente , Fatores Etários , Biópsia por Agulha/efeitos adversos , Criança , Pré-Escolar , Feminino , Hospitais Pediátricos , Humanos , Imuno-Histoquímica , Lactente , Recém-Nascido , Nefropatias/diagnóstico , Masculino , Medição de Risco , Gestão de Riscos , Sensibilidade e Especificidade , Índice de Gravidade de Doença , Fatores Sexuais , Turquia , População Urbana , Adulto Jovem
6.
Pediatr Nephrol ; 23(8): 1233, 1235-7, 2008 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-18183427

RESUMO

A 14-year-old girl was diagnosed with familial Mediterranean fever (FMF) with homozygous for M694V mutation of the MEFV gene and was started on colchicine therapy 4 years before admission to our hospital. She was uncompliant to therapy and was admitted to a local hospital with complaining of fever, malaise, abdominal pain and artralgia lasting for 2 months. Multiple hypoechogenic mass lesions were detected on liver and kidneys with ultrasonography (US) and diagnosed to be hematomas by laparoscopic examination. She was referred to our hospital because of development of convulsions. On physical examination her blood pressure was 140/90 mmHg and body temperature was 39 degrees C. She was pale and extremely cachectic, with atrophic muscles of the extremities. She had diffuse abdominal tenderness and hepatosplenomegaly. Laboratory investigations revealed a hemoglobin of 9.8 g/dl, white blood cell count 9,900/mm3, platelets 213,000/mm3, erythrocyte sedimentation rate (ESR) 112 mm/h, C- reactive protein (CRP) 78 mg/L (normal < 2 mg/L) and fibrinogen 500 mg/dl. Electrolytes, renal and hepatic functions and urinalysis were normal. Examinations of peripheric blood smear and bone marrow aspiration were normal. X-rays of bones and chest showed no pathological finding. Protrombine, partial thromboplastine and bleeding times were normal. Bacterial cultures of blood, urine and stool grew no organisms. Serological tests for hepatitis B and C, cytomegalovirus, salmonella and brucella were negative.


Assuntos
Febre Familiar do Mediterrâneo/complicações , Hematoma/etiologia , Poliarterite Nodosa/complicações , Adolescente , Angiografia , Educação Médica Continuada , Feminino , Hematoma/diagnóstico por imagem , Humanos , Poliarterite Nodosa/diagnóstico por imagem
7.
Pediatr Nephrol ; 20(1): 99-101, 2005 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-15549409

RESUMO

In nephrotic syndrome there is an increased tendency for bacterial infections due to immunological changes secondary to proteinuria, treatment (including steroids), and other as yet unknown causes. However, necrotizing fasciitis (NF) is an uncommon complication of the disease and has rarely been reported in nephrotic children. We report a 14-month-old boy with nephrotic syndrome who developed sepsis and NF as a complication. He was treated successfully with intensive medical and surgical treatment.


Assuntos
Fasciite Necrosante/etiologia , Síndrome Nefrótica/complicações , Fasciite Necrosante/microbiologia , Fasciite Necrosante/terapia , Glucocorticoides/efeitos adversos , Humanos , Lactente , Masculino , Síndrome Nefrótica/tratamento farmacológico , Prednisolona/efeitos adversos , Sepse/etiologia , Sepse/microbiologia , Sepse/terapia
8.
Am J Nephrol ; 25(5): 434-40, 2005.
Artigo em Inglês | MEDLINE | ID: mdl-16118480

RESUMO

BACKGROUND/AIMS: Evaluation of the risk factors, and phenotype-genotype correlation of familial Mediterranean fever (FMF) gene (MEFV) and serum amyloid A1 (SAA1) gene polymorphisms in renal amyloidosis. METHODS: We investigated MEFV and SAA1 genotypes (alpha, beta, and gamma isoforms) in 50 FMF patients and 50 healthy children. Tel-Hashomer criteria were used for the diagnosis and severity scoring of FMF. RESULTS: The most common MEFV mutation and SAA1 genotype were M694V/M694V (n = 26/50) and SAA1 alpha/alpha (n = 26/50), respectively. Positive family history for amyloidosis was significantly higher (p < 0.001) with more severe clinical course (p = 0.006) in the amyloidosis group than the non-amyloid group. In M694V/M694V mutation, erysipelas-like skin erythema (p = 0.029), arthritis (p = 0.004), arthralgia (p < 0.001) were significantly more frequent with higher severity scores (p = 0.008) than the patients with other mutations. Comparison of the SAA1 alpha/alpha genotype with other genotypes revealed more frequent arthritis (p = 0.003) in the SAA1 alpha/alpha genotype. In amyloidosis group patients having both M694V/M694V and SAA1 alpha/alpha genotypes were the largest subgroup (n = 14, p < 0.001). Logistic regression analysis for amyloidosis corrected risk revealed a 1.2 times increase in M694V/M694V, a 2.4 times increase in SAA1 alpha/alpha genotypes and a 2.5 times increase when both are together. CONCLUSION: Positive family history for amyloidosis and presence of SAA1 alpha/alpha genotype in M694V/M694V mutation may predispose to amyloidosis by increasing the clinical severity. Therefore, in such children early colchicine treatment might be recommended even if they are asymptomatic.


Assuntos
Amiloidose/genética , Febre Familiar do Mediterrâneo/genética , Predisposição Genética para Doença , Adolescente , Adulto , Amiloidose/fisiopatologia , Criança , Pré-Escolar , Feminino , Genótipo , Homozigoto , Humanos , Modelos Logísticos , Masculino , Prontuários Médicos , Metionina , Proteína Amiloide A Sérica/genética , Índice de Gravidade de Doença , Valina
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA